Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
just watch the "BUZZ" build up this whole weekend-
as K.R. releases the retail outlets to buy PAOG products.
this is gonna be one helluva HOTT stock by MONDAY morning $$$$$$$
DOC- I see K.R. expanding PAOG PRODUCTS into-
every state soon. the man is the " MASTER OF REVENUES " !
WITH OVER $ 100 MILLION DOLLARS WORTH WITH HIS LAST GIG, WITH OVER 9,000 AFFILIATES !!!
AAAAAHEEEEM ! LOOKIE-LOOKIE ! -
AT THOSE BEAUTIFUL CANNOPHEN PACKS NOW ON SALE AT RETAIL STORES !
THIS MUCH WE DO KNOW-
the $ 100 MILLION REVENUE MAN IS KICKING THIS INTO HIGH GEAR NOW !
GO PAOG $$$$$$
REMEMBER FOLKS- KARL DID SAY REVENUES-
starting in the 3RD Q ! the man is good on his word !
RETAIL STORES SOON TO BE ANNOUNCED !!!!- WALMART ? -
C.V.S. ? 7-11 ? KARL will let the cat out of the bag when he is ready !
GO PAOG $$$$$$$
"WE PLAN TO PROVIDE UPDATES WITH STORE LOCATIONS FOR -
RETAIL PURCHASE. STAY TUNED " !
KARL RIEDEL 'S plan is being executed just as he said it would !
LET'S KEEP IT GOING ,KARL $$$$$$$$$
THERE YOU HAVE IT !!!- CANNOPHEN IS NOW AVAILABLE -
FOR SALE AT SEVERAL SHOPS IN OHIO !
THIS IS JUST THE BEGINNING ,FOLKS !
HOLD ONTO YOUR SHARES- WE ARE GOING UP,UP,UP!!!!
THANKS FOR POSTING ,DOC !
GO PAOG $$$$$$$$$
SMART MARKETING-
GETTING OUR NAME BRAND OUT THERE .
PAOG $$$$$$
"Regarding PAOG, and my plans to dominate the Michigan cannabis market, I've done my best to give you all the roadmap for where we are headed.
I'm keeping alot of surprises up my sleeve regarding our MI cannabis company, because I'm excited to unveil the big surprise to shareholders. When the time is right. But I'm not letting the cat out of the bag yet. Stay tuned. "
SO-THERE IT IS !
agreed DOC ! -
as KARL has already said- he's keeping them up his sleeve for the right time to release. do doubt ,DISTRIBUTION DEALS ON THE WAY SOON !
let's just see where we are-
by late SEPTEMBER and OCTOBER ?
fair enuff ??
GO PAOG $$$$$
DOODE ! -when are you going to get -
it ?? DISTRIBUTION DEALS ARE COMING !
ALL IN "DOO "TIME. patience -DOO. like I said, I've been here for over 2 and half years, and KARL RIEDEL has accomplished more in past 3 months, than all others combined. are you forgetting this is the OTC/BB/PINKY land ? things don't happen overnite here, BUT it will happen. we are entering THE HOTTEST NEW INDUSTRY - "CBD"- that the world has ever experienced, since the dot.com era !!! WE'RE TALKING ABOUT $24 BILLION BUSINESS INDUSTRY HERE $$$$$$$$$$$
peace, doode…..
i don't care what anybody says-
I do believe K.R. is on the cusp of announcing REAL distribution deals lining up, AFTER ALL -the guy did have OVER 9,000 AFFILIATES with OVER $ 100 MILLION DOLLARS in REVENUES with his last company.
JUST STATING THE FACTS !
next please.....
The big question is: Just how big could the CBD market be?
Predictive analysis and market research company Brightfield Group believes it has the answer.
In a newly released report from Brightfield, the company is calling for year-over-year CBD product sales growth in the United States of 706% in 2019 to around $5 billion -- not a typo – and sales of $23.7 billion by 2023. Comparatively, about $620 million worth of CBD products were sold last year in the United States (based on 706% growth to $5 billion). Growing CBD revenue from about $620 million in 2018 to $23.7 billion by 2023 works out to (drum roll) a compound annual growth rate (CAGR) of a whopping 107%! Compare that to some of the most robust broad-based growth estimates for cannabis, which call for a CAGR of around 25%, and you can see why CBD is all the buzz (without creating an actual buzz) on Wall Street.
just a little patience, doo-
we'll get there in "doo" time.
PAOG $$$$$
that's great and congrads. to them-
but too bad one cannot purchase stock in their company ?
what's an investor to do ??
PAOG $$$$$
"Lightsky Farms LLC is a privately held company in Traverse City, MI and is a Single Location business".
I've never even heard of any -
of those products. 'course they've probably never heard of HIGH END products , either. lol. -at least not yet.
thanks for posting, pirate.
GO PAOG $$$$$
the CBD LOCOMOTIVE just keeps on rolling-
HIGH END PRODUCTS FOR SALE IN OHIO NEXT ??-
Ohio’s Governor Just Signed a Bill Legalizing the Sale of Hemp and CBD
The new law also requires that CBD oil previously confiscated be returned to the seller.
By A.J. Herrington
Republican Gov. Mike DeWine of Ohio signed a bill on Tuesday that legalizes hemp agriculture and sales of products made from the crop, including CBD. The measure, Senate Bill Number 57, decriminalizes hemp cultivation and establishes a system to license growers and processors. DeWine signed the bill on Tuesday morning during an appearance at the Ohio State Fair.
The bill also removes hemp derivatives other than THC from the state’s list of controlled substances, opening the door in Ohio for legal sales of CBD oil for use as a dietary or health supplement. Under previous state law, hemp was a Schedule I controlled substance like all other varieties of the plant Cannabis sativa. Senate Bill 57 amended state law so that it now conforms with the federal legalization of hemp passed by Congress with the 2018 Farm Bill.
S.B. 57 also requires that CBD oil previously confiscated be returned to the seller, provided that the product conforms with federal law. In August of last year, the Ohio Board of Pharmacy released a statement requiring CBD products to be sold only at state-licensed medical marijuana dispensaries. That decision led many retailers to pull CBD products from their shelves while some openly flaunted the ruling. Others had their merchandise confiscated and embargoed by authorities.
Rules for Hemp Program Already Being Drafted
The bill tasks the Ohio Department of Agriculture with creating a regulatory system to license hemp farmers and processors. Rules for the program are already being drafted and there are currently no plans to limit the number of licenses, which should be available by next year’s growing season. Dorothy Pelanda, the director of the agriculture department, said that staff at the agency have been studying hemp regulatory programs in other states in anticipation of creating the rules for Ohio.
“We want to make sure that Ohio has the very best hemp program in the nation,” Pelanda said, adding that she anticipates no problems drafting the regulations within the six-month time limit mandated by the bill.
The measure signed by DeWine on Tuesday also authorizes a hemp research program for the state. Ohio State University plans to purchase 2,000 hemp plants next week to study growing methods, pests, pathogens, and other issues.
Hemp Legalization Brings Economic Opportunity
Farmers and small business owners in Ohio have been eager to get into the growing CBD market, estimated to reach $26 billion by 2023. The Ohio Farm Bureau Federation has estimated that hemp could potentially be the state’s third most valuable crop after corn and soybeans.
Dave Arend opened his Your CBD Store in Anderson Township, Ohio despite the rule that CBD products be sold only in medical marijuana dispensaries. He said that the bill should lead to more customers coming to the store.
“I think this removes the stigma that what we sell is medical marijuana,’’ Arend said. “It’s not, and we definitely anticipate a lot more customers who want the benefit of CBD without the high of medical marijuana.’’
S.B. 57 goes into effect immediately with DeWine’s signature. The bill was passed by the Ohio House of Representatives earlier this month after being approved by the state Senate in March
doo -I hear you, and don't forget the-
big picture- CBD INDUSTRY is STILL in its INFANCY-
its NOT gonna go away anytime soon- its only going to GROW OVER 100 % YEAR-OVER YEAR in the coming years. CBD will be larger than MJ INDUSTRY !
GLTU
DOO-I "do" believe -
this is the NEW INDUSTRY we will be selling our products in :
The big question is: Just how big could the CBD market be?
Predictive analysis and market research company Brightfield Group believes it has the answer.
In a newly released report from Brightfield, the company is calling for year-over-year CBD product sales growth in the United States of 706% in 2019 to around $5 billion -- not a typo – and sales of $23.7 billion by 2023. Comparatively, about $620 million worth of CBD products were sold last year in the United States (based on 706% growth to $5 billion). Growing CBD revenue from about $620 million in 2018 to $23.7 billion by 2023 works out to (drum roll) a compound annual growth rate (CAGR) of a whopping 107%! Compare that to some of the most robust broad-based growth estimates for cannabis, which call for a CAGR of around 25%, and you can see why CBD is all the buzz (without creating an actual buzz) on Wall Street.
yes, please let's be realistic-
please show me another new C.E.O. , with OVER $ 100 MILLION in REVENUES under his belt with prior company, with NEW STELLAR PRODUCTS ABOUT TO ENTER AN INDUSTRY -THAT WOULD BE "CBD" INDUSTRY, THATS ABOUT TO BECOME A $24 BILLION DOLLAR BUSINESS ???
wow ! its so cool to see some of you guys-
have been holding PAOG (NWAV) as long as I have- early 2017.
our patience is about to finally pay-off BIG TIME $$$$$
SO TRUE- from WALMARTS TO -
7-11 STORES- NATIONWIDE !!!
HIGH END PRODUCTS ARE FIRST CLASS PRODUCTS $$$$
chill-out doo- you really need to read-
aphib's post -
# 146692
we are just in the first inning here. its a stepping process to success.
P-A-T-I-E-N-C-E.
sky- I know you are one of the long-term-
shareholders here ,like myself. I've been here over 2 1/2 years, and I believe you've been here longer. you have to admit we have seen more accomplished by K.R. in past few months, than the past 3 years before that. and that says a lot !
GLTU
you guys have to think about this-
how many new C.E.O.'s have pulled in OVER $ 100 MILLION in REVENUES with their last company ?? KARL RIEDEL knows exactly what he has here, and where he is taking this company, unlike many other otc/bb c.e.o.'s.
he is NOT your "average run-of-the -mill" guys. he has done everything he said he was going to do since he has taking this company over.
'NUFF SAID !!!
doo- gotta admit K.R. has done a lot in a very short period of time
since taking the reins here. i'd say in mater of weeks we will have distribution deals signed. NOT MONTHS OR YEARS. I hope you've got your shares now. or you will be chasing after them soon .
this stock sat at under .01-
for a long time, then it went parabolic , all way up to $ 3.23.
it happens in the otc/bb . many "pennystock millionaires " were made from OWCP. it is a shame to see it drop the way it has. BUT- it can rebound, I've seen it happen many times before. just don't forget to take profits on the way up. I do believe OWCP is worth buying a few million shares at current pps.
good luck to all
I don't know about this-
i'm closing in on 400 lbs., lol. I had trouble recently going up in a hot air balloon......
just watch this stock fly when the first -
of many distribution deals get signed. common sense tells us they are coming. K.R. is doing all the right things, and his plan is all coming together. let the bashers do their thing now, and watch them cry later. gonna be fun to watch this one develop.
PAOG = GREEN 4 OUT OF PAST 5 DAYS -
and first time we hit .003 in 5 weeks.
lookin good PAOG $$$$$$$
I agree, DOC-
now K.R. can start announcing new distribution deals, and
start cranking UP the REVENUES $$$$$$$
sure looked like they were busy this past weekend. i'm sure we'll be getting updates from K.R. this week.
The big question is: Just how big could the CBD market be?
Predictive analysis and market research company Brightfield Group believes it has the answer.
In a newly released report from Brightfield, the company is calling for year-over-year CBD product sales growth in the United States of 706% in 2019 to around $5 billion -- not a typo – and sales of $23.7 billion by 2023. Comparatively, about $620 million worth of CBD products were sold last year in the United States (based on 706% growth to $5 billion). Growing CBD revenue from about $620 million in 2018 to $23.7 billion by 2023 works out to (drum roll) a compound annual growth rate (CAGR) of a whopping 107%! Compare that to some of the most robust broad-based growth estimates for cannabis, which call for a CAGR of around 25%, and you can see why CBD is all the buzz (without creating an actual buzz) on Wall Street.
"just a little patience"-
Rising Biosciences Inc. Announces CBD Only Variant of Cannophen(TM) Begins Pilot Production Run, Coming to Market Soon
By AccessWire, July 16, 2019, 08:00:00 AM EDT
SANDUSKY, OH / ACCESSWIRE / July 16, 2019 /Rising Biosciences, Inc. (OTC Pink:RBII) ("Rising Biosciences" or the "Company") is pleased to announce that a CBD only variant of Cannophen™ Capsules and Vape Cartridges has entered into an initial production run.
Cannophen™ is Rising Biosciences' flagship product. Cannophen™ oral capsules and vape cartridges have been developed using strict standards set forward by the pharmaceutical compounding industry. Cannophen ™ features an alternative delivery system for rapid reception of the full metabolic benefits of beneficial compounds derived from the hemp plant. On June 8th of this year, the Company debuted Cannophen™ capsules and vape cartridges featuring 1 to 1 CBD and THC distillates at the High Times Cannabis Cup, Michigan, to an enthusiastic industry reception.
"I am thrilled that we can now launch our CBD only variant of Cannophen™," exclaimed Art Hall, CEO of Rising Biosciences. "This is the same premium Cannophen™ that we debuted in June, with the full spectrum of CBD distillates engineered to be rapidly bioactivated by the body, only this variant is non-THC."
Cannabidiol (CBD) is a non-psychogenic distillate derived from the stalks of the hemp plant. Mainstream consumers worldwide are increasingly becoming avid enthusiasts of the health and wellness benefits of CBD with sales of products containing the compound projected to exceed $5 Billion in 2019. The new CBD-only variant of Cannophen™ leverages unique opportunities for Rising Biosciences in two arenas:
1) CBD-only Cannophen™ is less encumbered by strict guidelines governing the distribution of products which contain THC. The Company can broaden its distribution footprint with fewer regulatory "pit-stops" along the way to reaching the deepest possible target market. Adding a CBD only product grants access to a global mainstream market demand that is growing in exponential fashion with no signs of slowing in the near-term future, according to many analysts. The Company will be able to deploy a deeper arsenal of marketing and distribution solutions for a CBD only product, including avenues such as online sales platforms.
2) Additionally, the CBD only Cannophen™ variant dovetails neatly with the segment of Rising Biosciences' business model specializing in physician and behavioral health facilities management for the treatment of substance abuse and mental health disorders. Growing numbers of clinical studies suggest that there is untapped potential in CBD as a treatment for a broad range of ailments from chronic anxiety to substance abuse disorder. Anxiety disorders are the most commonly diagnosed mental health illness in the USA today, affecting more than 40 million adults. Globally, the anxiety and depression treatment market has been valued at over $15 billion. Perhaps most promising, however, are the results from recent studies indicating that CBD may be a highly effective treatment for opioid use disorder. Initial results seem to indicate that CBD could change the face of opioid addiction treatment, succeeding where other conventional therapies have had mixed results.
"We are nearing the final stages of releasing CBD only Cannophen ™ for distribution," Stated Mr. Hall, "I have just received the UPC symbols for both the oral capsules and vape cartridges for our CBD only variant of Cannophen ™ . The first production run is done and initial samples are being sent to the lab for testing. Our debut run back in June tested at a full 25mg CBD per capsule, so we anticipate similar results for this batch of our CBD only variant. We are highly gratified to announce that CBD only Cannophen ™ will be coming to the market soon, both for what it will mean for our shareholders and for how it will advance our purpose in combating the opioid crisis in the Midwest and beyond. At the Rising Biosciences offices, we have been buzzing like a beehive in recent days working on new developments. We anticipate releasing more great news very soon.
the "awards show " was set -
for 2:20-3:30 pm e.s.t. we should be hearing something about the winners soon.
well then, if stiiizy wins, -
and we don't- we will scream "they paid the referees off", lol.
but -yes the competition looks tough. but its like they say- the competition makes you better.
yea, pirate- they are -
a relentless bunch, lol. they say 2 or 3 words, then repeat same thing over and over.
many people are failing -
to see just how BIG -PAOG is gonna be.
tick...tick...tick.....
alright, now I see the connection-
STIIILZY is a subsidiary of JUUL, which is the company that bought VMR-, which was the company KARL RIEDEL generated OVER $ 100 MILLION DOLLARS in REVENUES. HMMMMMMMM...…...